We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Domain Therapeutics Wins EUR 933,000 Grant for Schizophrenia Project

News   Mar 14, 2012

 
Domain Therapeutics Wins EUR 933,000 Grant for Schizophrenia Project
 
 
 

RELATED ARTICLES

Gout Get Outta Here

News

Researchers found a significant reduction in risk of gout attacks among patients who received the drug (canakinumab) that targets a key inflammatory molecule, suggesting a new target for therapeutic strategies to prevent gout attacks.

READ MORE

Cancer Drug & Antidepressants Provide Clues for Treating Fatal Brain-Eating Disease

News

Researchers have now identified three new molecular drug targets in N. fowleri, an amoeba that can infect a healthy person and cause severe primary amebic meningoencephalitis, a "brain-eating" disease The team have also identified a number of drugs that are able to inhibit the amoeba's growth in a laboratory dish.

READ MORE

Shedding Light on 100-Year-Old Cancer Mystery

News

Using genetic and pharmacological means, scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) were surprised to find that blocking LDHA had only a limited impact on melanoma cells, since they were able to redirect energy production. Their results identify an alternative growth pathway driven by a molecule called ATF4, revealing new potential targets for drug development.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE